Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 781 of 6351
-
New device aims to pull clots from the brain in major strokes
Disease control CompletedThe study aims to evaluate the safety and efficacy of the Supernova stent retriever device, developed by Gravity Medical Technology, for treating acute ischemic stroke. The device is used to remove blood clots and restore blood flow to the brain .
Sponsor: Gravity Medical Technology, INC • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New combo attack on biliary cancers: targeted drug plus chemo shows promise
Disease control OngoingThis phase II ComboMATCH treatment trial compares the usual treatment of modified leucovorin, fluorouracil and oxaliplatin (mFOLFOX6) chemotherapy to using binimetinib plus mFOLFOX6 chemotherapy to shrink tumors in patients with biliary tract cancers that have spread to other pla…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
New pill shows promise for rare, severe psoriasis
Disease control OngoingThe purpose of this study is to evaluate how effective JNJ-77242113 is in participants with generalized pustular psoriasis (GPP) or erythrodermic psoriasis (EP).
Phase 3 • Sponsor: Janssen Pharmaceutical K.K. • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can training therapists in LGBTQ-Affirmative CBT ease depression in marginalized communities?
Disease control CompletedThe purpose of the proposed study is to identify effective strategies for implementing lesbian, gay, bisexual, transgender, and queer (LGBTQ)- affirmative Cognitive-Behavioral Therapy (CBT) at LGBTQ community centers across the United States.
Sponsor: Yale University • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Middle school jitters: a new program aims to smooth the transition for anxious students
Symptom relief CompletedExcessive anxiety is a common problem that severely impairs short and long term academic functioning. The transition to middle school (MS) results in increases in anxiety and decreases in academic functioning. Students with anxiety in particular, due to their vulnerability to sch…
Sponsor: UConn Health • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
HIV breakthrough trial seeks to rescue failing treatments in africa
Disease control Recruiting nowThe RESOLVE trial is an open, parallel arm, randomized clinical trial which aims to determine the optimal strategy for management of virologic failure on antiretroviral therapy (ART) with tenofovir, lamivudine, and dolutegravir (TLD) in sub-Saharan Africa. The primary outcome of …
Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Clot removal may boost recovery in mild stroke patients
Disease control Recruiting nowPatients presenting with mild symptoms of acute ischemic stroke are common and account for approximately half of all acute ischemic stroke. About 30% of patients with minor stroke have a 90-day functional disability. Radiologically proven a large vessel occlusion (LVO) in patient…
Sponsor: First Affiliated Hospital of Wannan Medical College • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Could a simple procedure help mild stroke patients recover better?
Disease control OngoingExploring the Efficacy and Safety of Emergent Endovascular Treatment in Patients with Mild Ischemic Stroke Caused by Acute Anterior Circulation Large Vessel Occlusion based on Perfusion Imaging Screening
Sponsor: Zhangzhou Municipal Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New weekly shot shows promise for shedding pounds in obesity trial
Disease control CompletedThis study in China is open to adults who are at least 18 years old who are living with overweight or obesity. People with a body mass index (BMI) of 28 kg/m\^2 or higher or 24 kg/m\^2 or higher with at least 1 weight related problem can join the study. The main purpose of this s…
Phase 3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New eczema pill shows promise in late-stage trial
Symptom relief CompletedThis is a randomized, double-blind study comparing LNK01001 to placebo in participants with moderately to severely atopic dermatitis who were candidates for systemic therapy (ie, patients with a history of inadequate response to topical treatments, those who were using a systemic…
Phase 3 • Sponsor: Lynk Pharmaceuticals Co., Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
New hope for rare cancers: drug combo targets BRAF mutation
Disease control Recruiting nowThis study is a phase IV, pragmatic single-arm prospective, open label study in pediatric (1 years or older) and adult study participants with rare BRAF V600E mutation-positive unresectable or metastatic solid tumors for whom a decision has already been made to be treated with da…
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New combo therapy targets tough lung cancer
Disease control OngoingThis study is for patients with advanced/metastatic non-small cells lung cancer (NSCLC) who have not received any treatment through the vein for the advanced disease.
Phase 2 • Sponsor: Eikon Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New hope for tough lymphoma: phase 3 trial pits SHR2554 against standard drug
Disease control Recruiting nowThis study was designed to compare the efficacy and safety of SHR2554 with Chidamide in patients with relapsed/refractory PTCL.
Phase 3 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New drug combo could spare chemo for some breast cancer patients
Disease control Recruiting nowADAPT-HER2-IV will address question of optimal neoadjuvant therapy in patients with less advanced -HER2+ EBC. ADAPT-HER2-IV is planned as a superiority trial to demonstrate higher pCR rates in both clinically relevant subgroups of low-intermediate risk HER2+ EBC. Moreover, it ai…
Phase 2 • Sponsor: West German Study Group • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Nerve switch surgery aims to restore arm movement in paralysis
Disease control Recruiting nowThe goal of this observational study is to determine if nerve transfer surgeries improve upper extremity function and quality of life in patients with a high level cervical spinal cord injury. Participants will: * undergo standard of care pre- and post-op testing and study exam…
Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Growing heart valve could spare kids repeat surgeries
Disease control OngoingProspective, single-arm, multi-center study to evaluate safety and effectiveness of the Autus Size-Adjustable Valve in pediatric patients aged 18 months to 16 years requiring surgical pulmonary valve replacement. The Autus Valve may be expanded pre-implant to match the subject's …
Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New hope for lymphoma patients: drug combo aims to keep cancer at bay longer
Disease control OngoingFollicular lymphoma (FL) is the second most common B-cell cancer and the most common type of cancer of lymphocytes. Unfortunately, this disease is incurable with conventional treatment and the disease recurs in almost all patients. This study will assess how safe and effective ep…
Phase 3 • Sponsor: Genmab • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
New combo therapy aims to save rectums from surgery in rectal cancer trial
Disease control Recruiting nowphase II clinical trial to evaluate node-sparing short-course radiation combined with total neoadjuvant CAPOX and Sintilimab for MSS locally advanced rectal cancers.
Phase 2 • Sponsor: Jinhua Central Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Blood protein test aims to catch liver cancer sooner
Diagnosis Recruiting nowBy collecting blood samples from liver cancer patients and healthy individuals, and comparing the blood protein profiles of the two, the biomarkers for early diagnosis and tissue traceability were identified to accurately establish an early diagnosis model for liver cancer and ve…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Diagnosis
Last updated Jun 27, 2026 12:38 UTC
-
Could intense workouts reverse cognitive decline in older HIV patients?
Disease control Recruiting nowThis is a single site, randomized exercise trial with individuals at least 50 years of age living with HIV who experience suboptimal cognition. The overall goals of this proposal are to determine whether 16 weeks of structured high-intensity interval training (HIIT) can overcome …
Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC